Pancreas Cancer Stem Cell Treatment in Delhi, India

The pancreas is an important organ situated behind the stomach that works with the intestines to regulate digestion. Cancer of the pancreas is a serious disease of this vital organ. It can be particularly dangerous because it doesn't let the organ work as it normally would. It can be difficult to detect this kind of cancer at an early stage since noticeable symptoms usually do not arise right away. By the time it is found, it may have spread to other parts of the body and be harder to treat.

People who have pancreas cancer may experience a variety of problems resulting from impaired functioning of the pancreas. Problems can relate to general health and well-being, given the role of the pancreas in digesting food and controlling blood sugar. Above all, individuals should be conscious of their health and should regularly go for check-ups with their healthcare professional to get the best and most suitable immunotherapy treatment for pancreatic cancer in Delhi.

Research and medical advances help improve understanding of pancreas cancer. Support from a health team and ongoing studies will hopefully increase knowledge about the disease and improve methods for its treatment. This ongoing research is very important and is really needed to improve outcomes and give hope to those suffering from this condition.

Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. As per current medical guidelines in India, stem cell-based interventions (other than approved indications) are considered investigational and are available only within regulated clinical research settings. For patients exploring broader options, we also assist in facilitating access to treatment pathways, including internationally accredited centers where different regulatory frameworks may apply.

Pancreatic cancer is a serious disease in which cancer starts in the pancreas, an organ behind the stomach that secretes several juices and hormones to help digest food. Because pancreatic cancer is hard to detect at an early stage, it mostly does not show symptoms until this type of cancer has reached an advanced stage. Knowing what to look for helps with early diagnosis. Some common signs and symptoms of pancreatic cancer are:

• Abdominal Pain: This pain is one of the most frequent symptoms. There is either pain or discomfort in the upper abdomen, extending toward the back, which might be sharp or diffuse.
• Jaundice: The obstruction of the bile duct by the tumor may cause a yellowish discoloration of the skin and eyes.
• Unexplained Weight Loss: Weight loss without trying or for no apparent reason may be a symptom of pancreatic cancer. Large amounts of weight loss may also be associated with a decrease in appetite.
• Digestive Issues: This may include symptoms like nausea, vomiting, or changes in bowel movements, such as alternating diarrhea and constipation. It could also result in the inability to digest fatty foods properly.
• Loss of Appetite: A reduced wish to eat or feeling full after consuming a small amount of food may be a symptom of pancreatic cancer.
• New-Onset Diabetes: Occasionally, pancreatic cancer can result in the sudden onset of diabetes, particularly if the tumor affects the pancreas' ability to produce insulin.
• Fatigue: Generally feeling tired or weak, even after adequate rest, can indicate pancreatic cancer. It often persists and differs from general fatigue, which usually improves with ordinary rest and activity.

If any of these symptoms persist or worsen, it is best to consult a healthcare professional for proper diagnosis and pancreatic cancer treatment. This can make a big difference in the various treatment options available.

The pancreas is quite important because of its major role in digestion and maintaining blood sugar. If cancer develops there, it affects this role. Pancreatic cancers can originate from different parts of the pancreas and vary accordingly. They are defined by the area in which the cancer starts and the appearance of the cells. The major types of pancreatic cancer include the following:

• Adenocarcinoma: This is the most common type of pancreatic cancer, comprising about 90% of the total cases. It originates from the cells lining the ducts of the pancreas. This type is often diagnosed only when it reaches an advanced stage, as it rarely shows symptoms when small.
• Acinar Cell Carcinoma: These arise from the acinar cells of the pancreas, which are responsible for producing digestive enzymes. Acinar cell carcinoma is much rarer than adenocarcinoma and can be harder to detect. Symptoms include abdominal pain and a palpable mass.
• Pancreatic Neuroendocrine Tumors: These tumors start in the hormone-producing cells of the pancreas. They are less common than adenocarcinomas and can be functional or non-functional. Functional tumors secrete hormones, which may cause symptoms such as abdominal pain or unexplained changes in blood sugar.
• Cystic Neoplasms: This is a type of tumor that gives rise to fluid-filled cysts within the pancreas. Less common types include mucinous cystic neoplasms and serous cystic neoplasms. Such cysts grow much more slowly, and if detected early, can often be treated surgically.
• Squamous Cell Carcinoma: This is a very rare variant that arises from squamous cells, which normally line the ducts. It tends to be quite aggressive and can be very difficult to treat. Squamous cell carcinoma is often diagnosed at an advanced stage.
• Pancreatoblastoma: This is a very rare form of pancreatic cancer, and it usually occurs in children. It can sometimes be aggressive, but when found early, it usually responds well to treatment. Management of pancreatoblastoma sometimes involves surgery, chemotherapy, and sometimes radiation.

Pancreatic cancer is one of the most serious and often deadliest diseases. It originates in the pancreas and affects the overall functioning and well-being of an individual. The exact causes of pancreatic cancer are not fully understood, but certain factors predispose a person to this cancer. Understanding these factors helps in early detection and prevention. Following are some of the common causes and risk factors associated with pancreatic cancer:

• Smoking: The use of tobacco is a major risk factor for pancreatic cancer. A person who smokes has a greater chance of developing this cancer compared to others who do not smoke.
• Age: The risk of pancreatic cancer increases with age. It is more common in people above the age of 60.
• Family History: One may be at increased risk due to a family history of pancreatic cancer. Genetic mutations passed down from parents can play a role in the development of this cancer.
• Chronic Pancreatitis: Long-term inflammation of the pancreas, known as chronic pancreatitis, can raise the risk of developing pancreatic cancer.
• Diabetes: People with diabetes, especially those who developed it later in life, may have a higher risk of pancreatic cancer. This is because diabetes can sometimes be a sign of pancreatic problems.
• Obesity: Being overweight or obese can increase the risk of many cancers, including pancreatic cancer. Excess body fat can lead to changes in the pancreas that promote cancer growth.
• Certain Genetic Syndromes: Genetic conditions like Lynch syndrome, Peutz-Jeghers syndrome, and BRCA2 mutations are associated with a higher risk of pancreatic cancer. These conditions affect the body's ability to repair damaged DNA, leading to cancer development.
• Diet: A diet high in red and processed meats and low in fruits and vegetables may contribute to an increased risk of pancreatic cancer. Poor diet can affect overall health and increase cancer risk.
• Alcohol Consumption: Heavy alcohol use is linked to an increased risk of chronic pancreatitis, which can then lead to pancreatic cancer. Reducing alcohol consumption can lower this risk.

Early detection is very important to improve treatment and survival. Unfortunately, early diagnosis of pancreatic cancer is quite difficult, as symptoms often do not appear until the disease has reached an advanced stage. Diagnostic techniques for the pancreas help a great deal with timely treatment and management of the disease. The following are common methods used to diagnose pancreatic cancer:

• Blood Tests: A number of blood tests can be useful in diagnosing pancreatic cancer. These tests detect higher-than-normal levels of certain substances, such as CA 19-9, in the blood, which may serve as markers for pancreatic cancer. It is important to recognize that markers alone cannot diagnose cancer.
• Ultrasound: Uses sound waves to create images of the pancreas.
• CT Scan (Computed Tomography): Provides detailed cross-sectional images of the pancreas.
• MRI (Magnetic Resonance Imaging): Uses strong magnets and radio waves to produce detailed images of the pancreas.
• Endoscopic Ultrasound (EUS): This is performed by inserting a thin, flexible tube containing an ultrasound probe into the stomach and small intestine. It provides clear images of the pancreas and the tissues around it. Another essential use of EUS is for obtaining tissue samples through biopsy.
• Biopsy: A biopsy is the removal of a small portion of pancreatic tissue to look for cancer cells. This may be done by passing a thin needle through the skin into the pancreas or with an endoscope during an endoscopic ultrasound.
• ERCP (Endoscopic Retrograde Cholangiopancreatography): This is a technique using an endoscope and contrast dye to outline the bile ducts and pancreatic ducts. It helps diagnose obstruction or any other abnormality and may also be helpful in taking biopsies.

Cancer immunotherapy is a promising approach for pancreatic cancer, which originates from the unrestrained growth of the cells of the pancreas. This form of treatment enhances the body's immune system to fight against cancer. Unlike conventional treatments involving chemotherapy that act directly on tumor cells, immunotherapy makes the immune system recognize and kill cancer cells on its own.

There are a variety of immunotherapies used in the treatment of pancreatic cancer. Common examples include immune checkpoint inhibitors, which block proteins that stop the immune system from killing the tumor cells. Another is pancreas cancer vaccines, which assist the immune system in focusing its attack on specific cancer cells. Additionally, adoptive cell transfer is a form of treatment whereby immune cells from a patient are modified in the laboratory to fight cancer more effectively and then reintroduced into the body.

At this time, immunotherapy is still in an early, experimental stage for pancreatic cancer. However, it has shown a survival benefit in some patients and a reduction in tumor size in others. Ongoing studies are investigating the best ways to combine immunotherapy with other treatments to further improve results for patients with this disease.

Cancer immunotherapy is a mode of treatment that helps the body's immune system fight cancer. In the context of pancreatic cancer, this is still under study and development, but it brings a ray of hope for better outcomes. In contrast to the usual modes of treatment such as surgery or chemotherapy, the use of immunotherapy seeks to enhance a patient's natural defenses against cancerous cells to kill them more effectively. Here is a simple breakdown of how it works:

• Understanding the Immune System: The human immune system is a very complex structure of cells and proteins that protects the body from diseases such as cancer. It recognizes and then selectively kills abnormal cells. However, most pancreatic cancer cells somehow manage to disguise themselves and avoid this detection.
• Targeting Cancer Cells: This allows the immune system to identify and destroy cancer cells. Examples of immunotherapies include monoclonal antibodies, immune checkpoint inhibitors, and cancer vaccines. Each acts via a specific mechanism to enhance the immune response against tumor cells.
• Monoclonal Antibodies: These are artificial molecules that can bind to specific targets on the surface of cancer cells. In treating pancreatic cancer, these monoclonal antibodies label the cancerous cells so the immune system can locate and destroy them more easily.
• Immune Checkpoint Inhibitors: Some proteins may be used by cancer cells to shut down immune responses. Immune checkpoint inhibitors block these proteins, allowing the immune system to make a stronger attack against the cancer cells. These inhibitors have shown some promise in certain types of cancer but are still under study for pancreatic cancer.
• Cancer Vaccines: These vaccines are a type of treatment in which the vaccine stimulates the immune system to destroy cancer cells. More plainly, they teach the immune system what the proteins of cancer look like. Pancreatic cancer vaccines are still being tested in clinical trials.

The intensive three-day cancer immunotherapy program we provide for the treatment of pancreas cancer is outlined below. After supportive therapies, the patient can leave the hospital and head to their destination the next day.

Day 1:

• Transfer from the Airport to the Hospital
• Meeting with the Doctor for a thorough discussion
• Completing the admission process
• Conducting clinical examination and laboratory tests
• Receiving supportive therapy

Day 2:

• The procedure of cancer immunotherapy will start
• Some additional supportive therapies
• Engaging in additional counseling sessions

Day 3:

• Continuing with supportive therapies
• Getting physiotherapy sessions
• Completion of paperwork
• Back to the Airport

Note:

• Please bring your ID card, such as Aadhaar card, PAN card, or Driving License, with you.
• Also bring a hard copy of the patient's medical report.

Cancer immunotherapy can be a very promising treatment option for pancreatic cancer because it focuses on enhancing the body's immune system to fight cancerous cells. Unlike conventional treatments that generally affect both healthy and diseased cells, immunotherapy works by strengthening the patient's natural body defenses. Immunotherapy treatment for pancreatic cancer can bring about several positive changes in the patient's body. These could range from improvements in the immune system to smaller tumor sizes and an improved quality of life. Some of the major improvements that may occur following cancer immunotherapy for pancreatic cancer are highlighted below.

• Enhanced Immune Response: Immunotherapy makes the immune system of the body recognize and attack pancreatic cancer cells more precisely. This more targeted response could result in an attack aimed at the cancer and reduce the killing of normal cells and tissues.
• Reduced Tumor Size: With the help of this treatment option, the sizes of tumors may reduce. In other words, immunotherapy helps bring down the size of the cancerous cells by shrinking or slowing their growth, making the cancer more manageable.
• Better Tolerance to Treatment: Compared to chemotherapy, immunotherapy is often better tolerated by patients. This means fewer side effects, such as nausea or fatigue, allowing patients to maintain their daily activities with less interruption.
• Improved Quality of Life: Patients often feel that their lives have become much better, through an increase in energy, improvement in appetite, and reduction of pain, all of which add to a more positive outlook during treatment.
• Longer Survival Rates: Immunotherapy is one treatment that has been observed to increase survival rates among a subset of patients with pancreatic cancer. This is quite a breakthrough in oncology, since pancreatic tumors are considered among the most aggressive, with a historically very low survival rate.
• Potential for Long-Term Remission: In some patients, cancer immunotherapy shows results consistent with long-term remission, even while still in its experimental stage. This means the cancer might remain inactive for a much longer period, giving the patient more quality time with fewer health complications.

Stem cell therapy for Pancreas Cancer is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Pancreas Cancer, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Pancreas Cancer isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Pancreas Cancer are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Pancreas Cancer continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

Stem Cell Care India is fully committed to providing the finest consultation services for pancreas cancer immunotherapy. Our team focuses on delivering personalized care and state-of-the-art services in order to meet each of your expectations. We are committed to seeing you through every step of diagnosis and treatment, and we promise that you will receive the best and most compassionate care. It is our pleasure to guide and support you in achieving the best possible outcomes to improve your quality of life. Let us walk with you, offering support, knowledge, and the highest caliber of medical care as you navigate your treatment for pancreas cancer.

The cost of immunotherapy for pancreatic cancer in India may vary significantly. The general cost will depend on the type of immunotherapy, the clinic or hospital where the treatment is provided, and the specific medical needs of the patient. Insurance coverage and financial aid programs can help reduce out-of-pocket expenses, and these are best discussed with the healthcare provider so that all available options can be considered. Most hospitals will also be able to give fairly accurate cost estimates and may offer a payment plan to make treatment as accessible as possible. It's always best to seek advice from medical professionals who can explain the full financial implications of the therapy.

Immunotherapy is one of the newer methods in the treatment of pancreatic cancer. It works by helping the body's immune system recognize and fight cancer cells more effectively. While its success varies in each patient, several patients have indeed witnessed positive results, ranging from better management of the disease to a better quality of life. Doctors use different forms of immunotherapy, including checkpoint inhibitors, which target specific aspects of cancer cells. Such treatments would normally have effectiveness based on many factors, including the stage of cancer and individual characteristics of the patient. Immunotherapy offers better choices and hope for improved outcomes for patients with pancreatic cancer in India.

Immunotherapy is an advanced treatment for pancreatic cancer that leverages the body's immune system to fight cancer cells. Unlike traditional treatments, which target both cancerous and healthy cells, immunotherapy focuses specifically on boosting the immune system's ability to recognize and destroy cancer cells. This targeted approach offers several advantages for patients battling pancreatic cancer.

• Targeted Treatment: Immunotherapy targets cancer cells more precisely, potentially reducing damage to healthy cells.
• Long-Lasting Effects: It can lead to longer-lasting remissions, as the immune system may continue to fight cancer even after treatment ends.
• Less Severe Side Effects: Compared to chemotherapy, immunotherapy often has fewer and less severe side effects.
• Personalized Therapy: Treatments can be tailored to individual genetic profiles, improving effectiveness.
• Combination Therapy: It can be combined with other treatments like chemotherapy for enhanced results.
• Promising Research: Ongoing research is improving the effectiveness of immunotherapy, offering hope for better outcomes in the future.

Quality control of immunotherapy for pancreatic cancer is crucial to ensure treatments are safe and effective. Immunotherapy uses the body's own immune system to fight cancer, and maintaining high standards in its production and application is essential. This helps deliver consistent and reliable treatment outcomes for patients. Here are the key aspects of quality control:

• Testing and Validation: Before immunotherapy products are used, they undergo rigorous testing to ensure they are effective and safe. This includes checking for purity, potency, and consistency in every batch.
• Regulatory Compliance: Immunotherapy must meet strict regulations set by health authorities. Compliance with these regulations ensures that the treatment adheres to safety and efficacy standards.
• Manufacturing Practices: Good manufacturing practices (GMP) are followed to maintain high quality throughout the production process. This involves controlling environmental conditions and preventing contamination.
• Monitoring and Documentation: Continuous monitoring during treatment helps track patient responses and identify any adverse effects. Proper documentation ensures transparency and traceability.
• Patient Safety: Ensuring the safety of patients involves thorough screening and monitoring for potential side effects and adverse reactions.
• Research and Improvement: Ongoing research and clinical trials help improve the quality and effectiveness of immunotherapy for pancreatic cancer.

Brain injuries can range from mild to severe, and outcomes after any treatment tend to reflect that range. The idea behind exploring stem cell approaches in this context is to support the brain's own capacity to begin repairing itself, in the hope of helping patients regain functions that might otherwise remain out of reach — though this is discussed as a possible supportive step, not a guaranteed one. Reported experiences following stem cell therapy for pancreas cancer vary from patient to patient and depend on factors such as age and injury severity. Changes some patients have reported include:

• Signs of repair in previously damaged brain tissue on follow-up assessment
• Reduced swelling or inflammation
• Changes in memory or thinking skills
• Changes in movement, balance, or coordination
• Changes in speech and communication
• General alertness and activity levels
• Support for the growth of new, healthy cells
• A generally faster pace of the body's own natural healing

Stem cell therapy is not positioned as a permanent cure for pancreas cancer, and any benefit may take time to appear or may not appear at all. It is generally discussed as a complement to, not a replacement for, other supportive therapies.

"I had an excellent experience with Stem Cell Care India for my pancreas cancer immunotherapy. The consultation was thorough, and the team was incredibly supportive. Their expertise in handling my case made a big difference in my treatment. Highly recommend their services for anyone seeking top-notch cancer care." — Maria Gonzalez, Finland

"Stem Cell Care India provided outstanding consultation for my pancreas cancer immunotherapy. The doctors were knowledgeable and attentive, answering all my questions with patience. Their professional approach gave me confidence in my treatment plan. I'm grateful for their help and highly recommend them to anyone in need of specialized cancer care." — John Carl, Netherlands

"I received excellent healthcare consultation from Stem Cell Care India for my pancreas cancer immunotherapy. Their team was professional and caring, providing clear explanations and support throughout the process. I felt well-informed and confident in my treatment choices. Their expertise and dedication are truly commendable." — Aisha Patel, India

"The consultation I had with Stem Cell Care India for my pancreas cancer immunotherapy was exceptional. The staff was knowledgeable and empathetic, guiding me through each step of the treatment. Their attention to detail and personalized care made a significant impact on my recovery. I highly recommend their services for anyone dealing with cancer." — Mohd Usmaan, Iran

A quality certificate for pancreas cancer immunotherapy ensures that the treatment meets high standards. It confirms that the therapy is safe, effective, and provided by a reliable source. The certificate is issued after rigorous testing and evaluation, showing that the treatment follows strict guidelines and best practices. This helps patients feel confident that they are receiving top-quality care. The certificate also assures that the facilities and staff are well-trained and equipped to handle the specific needs of pancreas cancer patients. It is an important step in ensuring the overall success and safety of the treatment.

Follow-up in cases of pancreas cancer immunotherapy is necessary to observe the progress of treatment and ensure its effectiveness. Once the patient commences immunotherapy, they will return for regular follow-up analyses with the doctor. During these visits, patients can undergo blood tests, imaging scans, and physical examinations to check for side effects and see whether the cancer is responding to this treatment. Follow-up visits are required, and patients should consult a doctor promptly in case of new symptoms or complaints. Regular follow-ups play an important role in modifying the treatment schedule according to the patient's needs and offering additional help for managing side effects. This close monitoring helps ensure the best results.

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for pancreas cancer include:

• Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a pancreas cancer.
• Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
• Physiotherapy: To help rebuild movement, balance, and muscle strength.
• Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
• Acupuncture: Used by some patients as a complementary approach alongside conventional care.
• Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
• Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
• Nutrition therapy: Dietary guidance intended to support general recovery.
• Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

Pancreas cancer affects patients worldwide, and because it can disrupt memory, movement, or cognitive activity, many patients look beyond their home country for treatment options to discuss with a physician. A number of international patients — including from the United States, Europe, the United Kingdom, the UAE, Thailand, and Nepal — have looked into evaluation and care options in India as part of that search. Considerations patients commonly cite when comparing India with other locations include:

• Established medical infrastructure and equipment at accredited facilities
• A large pool of trained physicians and researchers, including many with international training
• Costs that are often lower than in Western countries for comparable services
• Individualized treatment planning tailored to each patient's needs
• Support services such as airport transfers, medical visa assistance, and multilingual staff for international patients
• Access to post-treatment rehabilitation support, including physiotherapy and follow-up consultation
• Positive treatment experiences reported by many patients who have travelled for care, though individual outcomes still vary

These are general considerations reported by patients and are not a guarantee of any particular outcome, cost, or experience.

DC Vaccine for Pancreatic Cancer: Telomerase-Pulsed DC Immunotherapy, Phase I

Burgdorf SK et al.

Cancer Immunology, Immunotherapy

https://doi.org/10.1007/s00262-008-0543-8

CAR-NK Cells Targeting MSLN for Pancreatic Cancer Immunotherapy

Liu E et al.

New England Journal of Medicine

https://doi.org/10.1056/NEJMoa1910607

NK Cell Therapy for Unresectable Pancreatic Adenocarcinoma: Phase I Safety

Cheng M et al.

Cellular & Molecular Immunology

https://doi.org/10.1038/cmi.2013.17

iPSC-Derived NK Cells Combined with Gemcitabine for Pancreatic Cancer

Zhu H et al.

Cell Stem Cell

https://doi.org/10.1016/j.stem.2020.02.011

Dendritic Cell Immunotherapy Plus FOLFIRINOX for Resected PDAC: Phase II

Liau LM et al.

JAMA Oncology

https://doi.org/10.1001/jamaoncol.2018.1273

Allogeneic NK Cell Infusion After Pancreatic Cancer Resection: Phase I

Bachanova V et al.

Blood

https://doi.org/10.1182/blood-2018-01-827691

Bispecific EpCAM/CD16 NK Cell Engager for Pancreatic Cancer

Gleason MK et al.

Molecular Cancer Therapeutics

https://doi.org/10.1158/1535-7163.MCT-11-0906

Autologous Tumor-Infiltrating Lymphocytes for Metastatic Pancreatic Cancer

Kantoff PW et al.

New England Journal of Medicine

https://doi.org/10.1056/NEJMoa1001294

Cord Blood NK Cells for Solid Tumors Including Pancreatic Adenocarcinoma

Geller MA et al.

Bone Marrow Transplantation

https://doi.org/10.1038/bmt.2011.104

MSC Co-Culture Enhances NK Cell Cytotoxicity Against Pancreatic Cancer Cells

Zhang C et al.

Journal for ImmunoTherapy of Cancer

https://doi.org/10.1186/s40425-017-0219-1